Kura Oncology’s new drug, ziftomenib, is still under FDA Priority Review for adults with R/R NPM1-m AML, with a target
Patria (Nasdaq:PAX) announced unaudited results for Q3 2025, with Assets under Management surpassing $50 billion. $1.5 billion raised in the
Nintendo raised its sales forecast for the Switch 2 console, expecting to sell 19 million units by March 2026. In
Serstech Group reported financials for July to September 2025: Net sales at KSEK 7,765, EBITDA at -4,283, EBIT at -6,387,
British oil giant BP reported a stronger-than-expected third-quarter profit of $2.21 billion, beating analyst expectations. The company’s net profit was
In Q3 2025, Philips saw an 8% growth in comparable order intake, with group sales reaching EUR 4.3 billion and
Denny’s Corporation reported third-quarter results, including $113.2 million in total operating revenue and $10.4 million in total operating income. Domestic
Starbucks forms a joint venture with Boyu Capital to operate its locations in China, with Boyu paying $4 billion for
Vital Energy, Inc. reported a net loss of $353.5 million in the third quarter of 2025, with Adjusted Net Income
Greenlight Capital Re, Ltd. reported record quarterly underwriting income, leading to a combined ratio of 86.6% for the third quarter
Palantir Technologies Inc., led by CEO Alex Karp, surpassed analyst expectations and provided an optimistic outlook for the fourth quarter,
Shopify Inc. is expected to report a consensus earnings per share of $0.24 for the quarter ending September 30, 2025,
U.S. equities hit record highs in October, with the S&P 500 and Dow Jones up. Market breadth narrowed, value indices
Palantir Technologies Inc. (PLTR) is expected to report earnings with a forecasted EPS of $0.12, a 100.00% increase from last
The Finance sector is expected to see a 21.1% rise in total earnings in the third quarter of 2025, with
As more consumer companies prepare to report third-quarter earnings, signs of a “K-shaped” economy emerge. Wealthier Americans are spending more,
In the third quarter, AT&T’s revenue grew by 1.7%, slightly below expectations, but with in-line earnings of 54 cents per
Phase 3 PEAK trial results for 2nd-line GIST patients and pivotal APEX results for AdvSM patients expected in November and
Investors are encouraged to pair stocks from different sectors for strategic synergy. Luxury brands and payments companies benefit from global
Adeia Inc. announced financial results for Q3 2025, with revenue at $87.3 million and an impressive 58% adjusted EBITDA margin.
Cipher Mining Inc. reported third quarter 2025 revenue of $72 million and non-GAAP adjusted earnings of $41 million, marking a
Vertex, Inc. announced strong third-quarter financial results with total revenues of $192.1 million, software subscription revenues up 12.7% year-over-year, and
Pyxis Oncology expects to release preliminary data from ongoing Phase 1 clinical studies of MICVO for patients with recurrent and
TG Therapeutics, Inc. reported third quarter 2025 total revenue of $161.7 million, including BRIUMVI U.S. net revenue of $152.9 million.
ECARX Holdings Inc. announced unaudited financial results for Q3, 2025, with $8.3 million in Adjusted EBITDA and $0.9 million in
